4.7 Review

Transcatheter aortic valve implantation: 10-year anniversary. Part II: clinical implications

期刊

EUROPEAN HEART JOURNAL
卷 33, 期 19, 页码 2399-+

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehs223

关键词

Aortic stenosis; TAVI; TAVR

资金

  1. Edwards Lifesciences
  2. St Jude Medical

向作者/读者索取更多资源

Transcatheter aortic valve implantation (TAVI) has been increasingly recognized as a curative treatment for severe aortic stenosis (AS). Despite important improvements in current device technology and implantation techniques, specific complications still remain and warrant consideration. Vascular complications and peri-procedural neurological events were the first concerns to emerge with this new technology. Recently, significant post procedural para-valvular leak has been shown to be more frequent after TAVI than after surgical aortic valve replacement (SAVR), and its potential association with worse long-term prognostic has raised concerns. In moving toward treatment of lower risk populations, structural integrity and long-term durability of heat valve prosthesis are becoming of central importance. Emerging technologies and newer generations of devices seem promising in dealing with these matters.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据